CATALOGO DEI PRODOTTI DELLA RICERCA

Carbone, Carmine
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.342
EU - Europa 2.824
AS - Asia 1.858
SA - Sud America 252
Continente sconosciuto - Info sul continente non disponibili 91
AF - Africa 55
OC - Oceania 9
Totale 8.431
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.226
RU - Federazione Russa 980
SG - Singapore 658
CN - Cina 609
GB - Regno Unito 460
IT - Italia 422
DE - Germania 261
BR - Brasile 189
VN - Vietnam 186
HK - Hong Kong 183
FI - Finlandia 156
SE - Svezia 154
IE - Irlanda 126
FR - Francia 114
CA - Canada 61
KR - Corea 56
NL - Olanda 33
JP - Giappone 26
UA - Ucraina 26
BD - Bangladesh 24
TR - Turchia 24
AR - Argentina 23
IN - India 21
MX - Messico 21
ES - Italia 18
ID - Indonesia 18
BE - Belgio 15
ZA - Sudafrica 15
AT - Austria 14
PL - Polonia 13
JO - Giordania 10
NG - Nigeria 10
CO - Colombia 9
PY - Paraguay 9
AU - Australia 8
EC - Ecuador 8
GT - Guatemala 8
MA - Marocco 7
VE - Venezuela 7
JM - Giamaica 6
BJ - Benin 5
IQ - Iraq 5
PR - Porto Rico 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
CH - Svizzera 4
CR - Costa Rica 4
EG - Egitto 4
PH - Filippine 4
PK - Pakistan 4
TG - Togo 4
CL - Cile 3
CZ - Repubblica Ceca 3
EE - Estonia 3
EU - Europa 3
GR - Grecia 3
HN - Honduras 3
HR - Croazia 3
KE - Kenya 3
LT - Lituania 3
PE - Perù 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
DK - Danimarca 2
GD - Grenada 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NP - Nepal 2
PS - Palestinian Territory 2
SN - Senegal 2
SV - El Salvador 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BT - Bhutan 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GP - Guadalupe 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MG - Madagascar 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 8.345
Salva come PNG Salva come JPEG
Città #
Ashburn 544
Southend 383
Chandler 345
Moscow 342
Singapore 340
San Jose 296
Dallas 266
Hong Kong 174
Verona 164
Woodbridge 139
Dublin 126
Munich 126
Beijing 117
Jacksonville 117
Council Bluffs 92
Helsinki 92
The Dalles 76
Ann Arbor 72
New York 71
Jinan 53
Ho Chi Minh City 50
Los Angeles 46
Hanoi 44
Houston 42
Lawrence 37
Princeton 37
Redmond 37
Santa Clara 37
Wilmington 37
Nanjing 32
Shenyang 32
Tianjin 30
Tokyo 25
Hebei 24
São Paulo 23
Redondo Beach 22
Dong Ket 20
Turku 20
Montreal 19
Chicago 18
Milan 18
Buffalo 17
London 17
Orem 16
Atlanta 15
Brussels 15
Columbus 15
Haikou 15
Nanchang 15
Frankfurt am Main 14
Guangzhou 13
Jakarta 13
Seattle 13
Sindelfingen 13
Taiyuan 13
Washington 13
Zhengzhou 13
Bologna 11
Brooklyn 11
Changsha 11
Johannesburg 11
Ningbo 11
Phoenix 11
Toronto 11
Warsaw 11
Abuja 10
Boardman 10
Lappeenranta 10
Chennai 9
Jiaxing 9
Madrid 9
Redwood City 9
Rio de Janeiro 9
Rome 9
San Francisco 9
Vienna 9
Amman 8
Denver 8
Kent 8
Manchester 8
Mexico City 8
Amsterdam 7
Biên Hòa 7
Boston 7
Da Nang 7
Hangzhou 7
Norwalk 7
Querétaro 7
Stockholm 7
Ankara 6
Asunción 6
Barnet 6
Brasília 6
Fairfield 6
Haiphong 6
Jyväskylä 6
Nuremberg 6
Paris 6
Seoul 6
Taizhou 6
Totale 5.167
Salva come PNG Salva come JPEG
Nome #
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 395
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 332
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 325
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 304
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 277
Anti-VEGF treatment-resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype. 275
Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatment 266
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 245
NF-κB as a target for pancreatic cancer therapy. 226
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 222
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer 216
A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer 212
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 209
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients 203
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 203
Current Strategies to Overcome Resistance to ALK-Inhibitor Agents 201
Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance 197
An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis 196
Modulation of pancreatic cancer chemoresistance by inhibition of TAK1. 194
TGF-beta-activated Kinase 1 (TAK1) is a therapeutic target modulating pancreatic cancer chemoresistance 190
Small Molecule Inhibitors of Microenvironmental Wnt/β-Catenin Signaling Enhance the Chemosensitivity of Acute Myeloid Leukemia 187
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 181
PEROXIREDOXIN-2: A NOVEL REGULATOR OF IRON HOMEOSTASIS IN INEFFECTIVE ERYTHROPOIESIS 179
Local ablation disrupts immune evasion in pancreatic cancer 174
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 171
EMT and Treatment Resistance in Pancreatic Cancer 169
Molecular alterations in basal cell carcinoma subtypes 166
Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy 160
MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity 160
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC 156
Pro-inflammatory factors secreted by pancreatic cancers with evasive resistance to anti-VEGF treatment contribute to malignant progression by inducing EMT 156
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer 154
TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy 151
Toll-Like Receptor 9 Agonists for Cancer Therapy 151
MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC 149
Predictive biomarkers for the treatment of resectable esophageal and esophago-gastric junction adenocarcinoma: from hypothesis generation to clinical validation 147
Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversible by blood transfusion 140
PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around 134
Molecular analysis of a male breast cancer patient with prolonged stable disease under mTOR/PI3K inhibitors BEZ235/everolimus 129
Rationale and clinical use of multitargeting anticancer agents. 108
Systemic profile of immune factors in an elderly Italian population affected by chronic strongyloidiasis 93
Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat 90
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 84
Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer 84
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story 70
Totale 8.431
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.256
article - articoli 26.328
book - libri 0
conference - conferenze 966
curatela - curatele 0
other - altro 962
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.512
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022221 0 0 0 34 11 5 8 23 9 12 19 100
2022/2023801 68 101 72 144 52 196 4 46 95 7 10 6
2023/2024473 13 22 34 53 52 70 26 65 6 34 73 25
2024/20251.274 50 54 50 171 55 77 118 87 212 78 116 206
2025/20263.375 209 160 281 537 860 213 310 168 264 215 93 65
2026/2027620 32 92 114 382 0 0 0 0 0 0 0 0
Totale 8.431